drugset / Trial / NCT00379821

Chloroquine Alone or in Combination for Malaria in Children in Malawi

NCT00379821 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

Malaria is a sickness caused by a germ that can get into a person's body when a mosquito bites them. It can cause fever, headache, body aches and weakness. It can even cause death, especially in children. When malaria is treated with the appropriate medicine(s), it can be cured completely. The purpose of this study is to find out if it is better to use chloroquine alone or in combination with another drug to most effectively treat malaria. About 640 children with malaria, aged 6 months to 5 years of age, from the Blantyre Malaria Project Research Clinic at the Ndirande Health Center in Malawi will be in the study. They will be treated with either chloroquine alone or a combination of chloroquine plus another medication (azithromycin or artesunate or atovaquone-proguanil) every time they get malaria for a year. Blood samples will be collected and tested at least every 4 weeks. Participants will be involved in the study for 1 year.

Timeline

Start
2007-02
Primary completion
2009-08
Completion
2012-09

Outcome

Missed primary endpoint

registry Chloroquine Plus Artesunate vs CQ Monotherapy; p = 0.8097; Risk Ratio (RR) 1.0413 (95% CI 0.7497 to 1.4463) NCT00379821 ↗

registry Chloroquine Plus Atovaquone-Proguanil vs CQ Monotherapy; p = 0.3767; Risk Ratio (RR) 1.1623 (95% CI 0.8333 to 1.6211) NCT00379821 ↗

registry CQ Plus Azithromycin vs CQ Monotherapy; p = 0.6277; Risk Ratio (RR) 1.0707 (95% CI 0.7708 to 1.4872) NCT00379821 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Artesunate Small molecule 4 mg/kg —
Subject Atovaquone-proguanil Unknown — —
Subject Azithromycin Small molecule 30 mg/kg —
Subject Chloroquine Small molecule 5 mg/kg —